Follow Up Q&A – Antidepressant Utilization In Bipolar Disorder: What Is The Evidence?
Community Voices | March 28, 2018
Not a member? Sign up for free!
Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration. Sign up today for instant access to all PsychU offerings. Membership is free!
During this question and answer session, Joseph Goldberg, MD, Clinical Professor at the Icahn School of Medicine at Mount Sinai, shared additional case studies and respond to unanswered questions from their March 28, 2018 webinar entitled “Antidepressant Utilization In Bipolar Disorder: What Is The Evidence.” Watch the full webinar here: https://www.psychu.org/antidepressant-utilization-bipolar-disorder-evidence/
PsychU offers private, personalized educational programs, both online and in-person, on a range of topics, including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and health care policy.
Any PsychU member can request a presentation for their region or organization for free.
This link will take you outside of the PsychU community website.
By selecting continue, you will be leaving PsychU. The destination site to which you will be redirected is not controlled or endorsed by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and / or Lundbeck, LLC.